| Field | Row 1 |
|---|---|
| adsh | 0001641172-25-009263 |
| cik | 1360214 |
| name | HARROW, INC. |
| sic | 2834 |
| countryba | US |
| stprba | TN |
| cityba | NASHVILLE |
| zipba | |
| bas1 | 1A BURTON HILLS BLVD |
| bas2 | SUITE 200 |
| baph | 615.733.4731 |
| countryma | US |
| stprma | TN |
| cityma | NASHVILLE |
| zipma | |
| mas1 | 1A BURTON HILLS BLVD |
| mas2 | SUITE 200 |
| countryinc | US |
| stprinc | DE |
| ein | 450567010 |
| former | HARROW HEALTH, INC. |
| changed | 20181228 |
| afs | 2-ACC |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250508 |
| accepted | 2025-05-08 16:16:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | form10-q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-009263 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
| 0001641172-25-009263 | 20240331 | Capital Expenditures Incurred But Not Yet Paid | 89000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20241231 | Common Stock Shares Outstanding | 35622214.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Cost Of Goods And Services Sold | 10553000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Earnings Per Share Diluted | -0.3800 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Gain Loss On Investments | -1248000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Gross Profit | 32307000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -8939000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -11096000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Increase Decrease In Deferred Revenue | 37000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -299000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20241231 | Inventory Net | 10702000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Liabilities And Stockholders Equity | 364164000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Net Cash Provided By Used In Investing Activities | -110000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Net Income Loss | -17780000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
| 0001641172-25-009263 | 20240331 | Operating Expenses | 10171000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Corporate; | ||
| 0001641172-25-009263 | 20240331 | Operating Expenses | 5294000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001641172-25-009263 | 20250331 | Operating Expenses | 12309000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Corporate; | ||
| 0001641172-25-009263 | 20250331 | Operating Lease Liability Noncurrent | 8581000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Operating Lease Right Of Use Asset Amortization Expense | 194000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Other Nonoperating Income | 26000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Payments To Acquire Intangible Assets | 42000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20241231 | Prepaid Expense And Other Assets Current | 15329000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Research And Development Expense | 2149000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 34587000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 79000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Other Revenues; | ||
| 0001641172-25-009263 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 27694000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Branded; Product Or Service= Product Sales Net; | ||
| 0001641172-25-009263 | 20240331 | Selling General And Administrative Expense | 18642000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001641172-25-009263 | 20250331 | Selling General And Administrative Expense | 7522000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Compounding; Consolidation Items= Operating Segments; | ||
| 0001641172-25-009263 | 20231231 | Shares Outstanding | 35168260.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009263 | 20240331 | Shares Outstanding | 35380955.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009263 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 35000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009263 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -147469000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Shares Other | 108480.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009263 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Gross | 199216.0000 | shares | 1 | us-gaap/2024 | Award Type= Restricted Stock Units R S U; Title Of Individual= Director; | ||
| 0001641172-25-009263 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 2743.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Parent; | |||
| 0001641172-25-009263 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 35469638.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 35826452.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Accounts Payable And Accrued Liabilities Current | 39159000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20241231 | Accounts Payable And Accrued Liabilities Current | 41406000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Accounts Receivable Net Current | 77063000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 4169000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009263 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 4556000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 4556000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009263 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009263 | 20250331 | Amortization Of Intangible Assets | 4220000.0000 | USD | 1 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Acquired New Drug Applications; | ||
| 0001641172-25-009263 | 20241231 | Cash And Cash Equivalents At Carrying Value | 47247000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 66726000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 19479000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Contract With Customer Liability Current | 145000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Cost Of Goods And Services Sold | 15524000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Depreciation And Amortization | 432000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Earnings Per Share Basic | -0.3800 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20241231 | Employee Related Liabilities Current | 9496000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Goodwill | 332000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Gross Profit | 12708000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Compounding; | ||
| 0001641172-25-009263 | 20240331 | Income Taxes Paid Net | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009263 | 20240331 | Increase Decrease In Accounts Receivable | -8396000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Increase Decrease In Deferred Revenue | 101000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Increase Decrease In Employee Related Liabilities | -1891000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Interest Paid Net | 6392000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Net Cash Provided By Used In Operating Activities | 19668000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Net Income Loss | -13565000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-009263 | 20250331 | Net Income Loss | -17780000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009263 | 20240331 | Nonoperating Income Expense | -6637000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Nonoperating Income Expense | -6548000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Operating Expenses | 43539000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Operating Expenses | 809000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment Aggregation Research And Development; | ||
| 0001641172-25-009263 | 20250331 | Operating Lease Right Of Use Asset Amortization Expense | 217000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 13790000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Branded; Product Or Service= Product Sales Net; | ||
| 0001641172-25-009263 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | USD | 1 | us-gaap/2024 | Business Segments= Compounding; Product Or Service= Other Revenues; | |||
| 0001641172-25-009263 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 2321000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= I H E E Z O; | ||
| 0001641172-25-009263 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 2597000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= V E V Y E; | ||
| 0001641172-25-009263 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 86000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Branded; Product Or Service= Other Revenues; | ||
| 0001641172-25-009263 | 20240331 | Selling General And Administrative Expense | 28813000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -355000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
| 0001641172-25-009263 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -355000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
| 0001641172-25-009263 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 2743.0000 | shares | 1 | us-gaap/2024 | Award Type= Stock Option Plan One; | ||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009263 | 20250331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
| 0001641172-25-009263 | 20241231 | Accounts Receivable Net Current | 116373000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20241231 | Additional Paid In Capital | 221002000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009263 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009263 | 20250331 | Amortization Of Financing Costs And Discounts | 176000.0000 | USD | 1 | us-gaap/2024 | Longterm Debt Type= Senior Notes Due Two Thousand Twenty Seven; | ||
| 0001641172-25-009263 | 20240331 | Amortization Of Intangible Assets | 14000.0000 | USD | 1 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Patents; | ||
| 0001641172-25-009263 | 20241231 | Capitalized Computer Software Net | 1751000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Capitalized Computer Software Net | 1627000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 68538000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -5547000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Cost Of Goods And Services Sold | 3678000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Branded; | ||
| 0001641172-25-009263 | 20240331 | Cost Of Goods And Services Sold | 6875000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Compounding; | ||
| 0001641172-25-009263 | 20250331 | Cost Of Goods And Services Sold | 7343000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Compounding; | ||
| 0001641172-25-009263 | 20250331 | Employee Related Liabilities Current | 7605000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Gain Loss On Investments | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009263 | 20250331 | Income Taxes Paid Net | 38000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -321000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Intangible Assets Net Excluding Goodwill | 180765000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Liabilities | 308068000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20241231 | Long Term Notes Payable | 219539000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20241231 | Minority Interest | -355000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009263 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009263 | 20250331 | Net Income Loss | -17780000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001641172-25-009263 | 20240331 | Operating Expenses | -2273000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Branded; Consolidation Items= Operating Segments; | ||
| 0001641172-25-009263 | 20240331 | Payments To Acquire Property Plant And Equipment | 92000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Payments To Acquire Property Plant And Equipment | 170000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Proceeds From Stock Options Exercised | 23000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Provision For Doubtful Accounts | 114000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 20718000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Compounding; | ||
| 0001641172-25-009263 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 20051000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Compounding; | ||
| 0001641172-25-009263 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 5222000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= I H E E Z O; | ||
| 0001641172-25-009263 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 47745000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Product Sales Net; | ||
| 0001641172-25-009263 | 20240331 | Selling General And Administrative Expense | 6212000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Compounding; Consolidation Items= Operating Segments; | ||
| 0001641172-25-009263 | 20240331 | Share Based Compensation | 4169000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Share Based Compensation | 4556000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 225581000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009263 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009263 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 348000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001641172-25-009263 | 20241231 | Operating Lease Liability Current | 497000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Accrued Rebates And Copay Assistance | 31153000.0000 | USD | 0 | 0001641172-25-009263 | |||
| 0001641172-25-009263 | 20250331 | Additional Paid In Capital | 225581000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Amortization Of Financing Costs And Discounts | 976000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Amortization Of Financing Costs And Discounts | 195000.0000 | USD | 1 | us-gaap/2024 | Longterm Debt Type= Senior Notes Due Two Thousand Twenty Six; | ||
| 0001641172-25-009263 | 20250331 | Amortization Of Financing Costs And Discounts | 193000.0000 | USD | 1 | us-gaap/2024 | Longterm Debt Type= Senior Notes Due Two Thousand Twenty Six; | ||
| 0001641172-25-009263 | 20240331 | Amortization Of Intangible Assets | 10000.0000 | USD | 1 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Customer Relationships; | ||
| 0001641172-25-009263 | 20250331 | Amortization Of Intangible Assets | 4226000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20241231 | Assets Current | 189651000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Assets Current | 169535000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20241231 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Common Stock Shares Issued | 35654171.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20241231 | Goodwill | 332000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Increase Decrease In Employee Related Liabilities | -423000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Increase Decrease In Inventories | 14000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Interest Paid Net | 5340000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Notes Payable Current | 108313000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Payment Of Payroll Taxes Upon Vesting Of P S Us R S Us And Exercise Of Stock Options | 1157000.0000 | USD | 1 | 0001641172-25-009263 | |||
| 0001641172-25-009263 | 20250331 | Payment Of Payroll Taxes Upon Vesting Of P S Us R S Us And Exercise Of Stock Options | USD | 1 | 0001641172-25-009263 | ||||
| 0001641172-25-009263 | 20250331 | Research And Development Expense | 1993000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Branded; Consolidation Items= Operating Segments; | ||
| 0001641172-25-009263 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 13869000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Branded; | ||
| 0001641172-25-009263 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 8872000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Other Products; | ||
| 0001641172-25-009263 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 47831000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Selling General And Administrative Expense | 40513000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Selling General And Administrative Expense | 28204000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001641172-25-009263 | 20241231 | Stockholders Equity | 69652000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Stockholders Equity | 56451000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 70766000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001641172-25-009263 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 221002000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009263 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -355000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
| 0001641172-25-009263 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -151385000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009263 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 56451000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001641172-25-009263 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Gross | 29214.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Value Other | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Value Other | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009263 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | 29214.0000 | USD | 1 | us-gaap/2024 | Award Type= Restricted Stock Units R S U; Equity Components= Common Stock; Title Of Individual= Director; | ||
| 0001641172-25-009263 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009263 | 20241231 | Accrued Rebates And Copay Assistance | 39900000.0000 | USD | 0 | 0001641172-25-009263 | |||
| 0001641172-25-009263 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009263 | 20240331 | Amortization Of Intangible Assets | 2530.0000 | USD | 1 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Acquired New Drug Applications; | ||
| 0001641172-25-009263 | 20250331 | Cash And Cash Equivalents At Carrying Value | 66726000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 74085000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Earnings Per Share Diluted | -0.5000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Intangible Assets Net Excluding Goodwill | 51000.0000 | USD | 0 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Customer Relationships; | ||
| 0001641172-25-009263 | 20250331 | Intangible Assets Net Excluding Goodwill | 13000.0000 | USD | 0 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Licenses; | ||
| 0001641172-25-009263 | 20250331 | Intangible Assets Net Excluding Goodwill | 156000.0000 | USD | 0 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Patents; | ||
| 0001641172-25-009263 | 20241231 | Liabilities Current | 91343000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Minority Interest | -355000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Net Cash Provided By Used In Financing Activities | 23000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Net Cash Provided By Used In Operating Activities | -4628000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Net Income Loss | -13565000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009263 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-009263 | 20240331 | Operating Expenses | 7567000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Compounding; Consolidation Items= Operating Segments; | ||
| 0001641172-25-009263 | 20240331 | Operating Expenses | 2051000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment Aggregation Research And Development; | ||
| 0001641172-25-009263 | 20250331 | Operating Expenses | -3076000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Branded; Consolidation Items= Operating Segments; | ||
| 0001641172-25-009263 | 20250331 | Operating Lease Liability Current | 611000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Prepaid Expense And Other Assets Current | 15030000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Proceeds From Stock Options Exercised | 23000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009263 | 20241231 | Property Plant And Equipment Net | 3734000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Provision For Doubtful Accounts | -85000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Research And Development Expense | 64000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Compounding; Consolidation Items= Operating Segments; | ||
| 0001641172-25-009263 | 20240331 | Research And Development Expense | 98000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001641172-25-009263 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | USD | 1 | us-gaap/2024 | Business Segments= Compounding; Product Or Service= Other Revenues; | |||
| 0001641172-25-009263 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 20051000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Imprimis Rx; | ||
| 0001641172-25-009263 | 20240331 | Selling General And Administrative Expense | 12430000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Branded; Consolidation Items= Operating Segments; | ||
| 0001641172-25-009263 | 20250331 | Shares Outstanding | 35654171.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009263 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 60206000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -355000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
| 0001641172-25-009263 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 60561000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001641172-25-009263 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -169165000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Value Other | -1157000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Value Other | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009263 | 20250430 | Stock Issued During Period Value Restricted Stock Award Gross | 9670.0000 | USD | 0 | us-gaap/2024 | Award Type= Restricted Stock Units R S U; Equity Components= Common Stock; Subsequent Event Type= Subsequent Event; Title Of Individual= Director; | ||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 348000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
| 0001641172-25-009263 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 23000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009263 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 4169000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Amortization Of Financing Costs And Discounts | 906000.0000 | USD | 1 | us-gaap/2024 | Longterm Debt Type= Oaktree Loan; | ||
| 0001641172-25-009263 | 20250331 | Assets | 364164000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Change In Rightofuse Assets For Operating Lease Obligations Assumptions | 377000.0000 | USD | 1 | 0001641172-25-009263 | |||
| 0001641172-25-009263 | 20241231 | Common Stock Value | 35000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Cost Of Goods And Services Sold | 8181000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Branded; | ||
| 0001641172-25-009263 | 20240331 | Increase Decrease In Inventories | -57000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Liabilities Current | 186986000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Net Cash Provided By Used In Financing Activities | -809000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20241231 | Notes Payable Current | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-009263 | 20240331 | Operating Expenses | 30962000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Operating Expenses | 1886000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001641172-25-009263 | 20250331 | Operating Income Loss | -11232000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20241231 | Operating Lease Right Of Use Asset | 8554000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Payments To Acquire Intangible Assets | 18000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Proceeds From Stock Options Exercised | 348000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Research And Development Expense | 34000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Branded; Consolidation Items= Operating Segments; | ||
| 0001641172-25-009263 | 20250331 | Research And Development Expense | 224000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Compounding; Consolidation Items= Operating Segments; | ||
| 0001641172-25-009263 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 79000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Other Revenue; | ||
| 0001641172-25-009263 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 34508000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Product Sales Net; | ||
| 0001641172-25-009263 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 956000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Other Products; | ||
| 0001641172-25-009263 | 20250331 | Selling General And Administrative Expense | 20682000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Branded; Consolidation Items= Operating Segments; | ||
| 0001641172-25-009263 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 69297000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 46175.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009263 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Parent; | |||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 348000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 23000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001641172-25-009263 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 35826452.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 4169000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001641172-25-009263 | 20240331 | Amortization Of Financing Costs And Discounts | 178000.0000 | USD | 1 | us-gaap/2024 | Longterm Debt Type= Senior Notes Due Two Thousand Twenty Seven; | ||
| 0001641172-25-009263 | 20250331 | Amortization Of Financing Costs And Discounts | 1275000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Amortization Of Intangible Assets | 2554000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Amortization Of Intangible Assets | 3000.0000 | USD | 1 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Customer Relationships; | ||
| 0001641172-25-009263 | 20250331 | Capital Expenditures Incurred But Not Yet Paid | 5000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 47247000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-009263 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20241231 | Common Stock Shares Issued | 35622214.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Common Stock Shares Outstanding | 35654171.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Common Stock Value | 35000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Depreciation And Amortization | 465000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Insurance Premium Financed | USD | 1 | 0001641172-25-009263 | ||||
| 0001641172-25-009263 | 20250331 | Intangible Assets Net Excluding Goodwill | 256000.0000 | USD | 0 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Trademarks; | ||
| 0001641172-25-009263 | 20250331 | Intangible Assets Net Excluding Goodwill | 67000.0000 | USD | 0 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Trade Names; | ||
| 0001641172-25-009263 | 20241231 | Liabilities | 319674000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20241231 | Liabilities And Stockholders Equity | 388971000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Net Cash Provided By Used In Investing Activities | -212000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Net Income Loss | -13565000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001641172-25-009263 | 20250331 | Operating Expenses | 4962000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Compounding; Consolidation Items= Operating Segments; | ||
| 0001641172-25-009263 | 20241231 | Retained Earnings Accumulated Deficit | -151385000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Retained Earnings Accumulated Deficit | -169165000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 86000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Other Revenue; | ||
| 0001641172-25-009263 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 21516000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= V E V Y E; | ||
| 0001641172-25-009263 | 20241231 | Shares Outstanding | 35622214.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009263 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 70411000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 204635000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009263 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -133904000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009263 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 35000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009263 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 35000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Gross | 223928.0000 | shares | 1 | us-gaap/2024 | Award Type= Restricted Stock Units R S U; Title Of Individual= Director; | ||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Gross | 275000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009263 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 35469638.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20241231 | Intangible Assets Net Excluding Goodwill | 184949000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
| 0001641172-25-009263 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 4556000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001641172-25-009263 | 20240331 | Amortization Of Financing Costs And Discounts | 603000.0000 | USD | 1 | us-gaap/2024 | Longterm Debt Type= Oaktree Loan; | ||
| 0001641172-25-009263 | 20250331 | Amortization Of Intangible Assets | 3000.0000 | USD | 1 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Patents; | ||
| 0001641172-25-009263 | 20241231 | Assets | 388971000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Change In Rightofuse Assets For Operating Lease Obligations Assumptions | USD | 1 | 0001641172-25-009263 | ||||
| 0001641172-25-009263 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-009263 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20241231 | Contract With Customer Liability Current | 44000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Earnings Per Share Basic | -0.5000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Gross Profit | 24034000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Gross Profit | 10191000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Branded; | ||
| 0001641172-25-009263 | 20240331 | Gross Profit | 13843000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Compounding; | ||
| 0001641172-25-009263 | 20250331 | Gross Profit | 19599000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Branded; | ||
| 0001641172-25-009263 | 20250331 | Increase Decrease In Accounts Receivable | -39196000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Insurance Premium Financed | 450000.0000 | USD | 1 | 0001641172-25-009263 | |||
| 0001641172-25-009263 | 20250331 | Intangible Assets Net Excluding Goodwill | 180218000.0000 | USD | 0 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Acquired New Drug Applications; | ||
| 0001641172-25-009263 | 20250331 | Intangible Assets Net Excluding Goodwill | 4000.0000 | USD | 0 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= State Pharmacy Licenses; | ||
| 0001641172-25-009263 | 20240331 | Interest Expense Nonoperating | 5415000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Interest Expense Nonoperating | 6548000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Inventory Net | 10716000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Long Term Notes Payable | 112501000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
| 0001641172-25-009263 | 20240331 | Operating Income Loss | -6928000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20241231 | Operating Lease Liability Noncurrent | 8792000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Operating Lease Right Of Use Asset | 8337000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Other Nonoperating Income | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009263 | 20250331 | Property Plant And Equipment Net | 3568000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Research And Development Expense | 3026000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Research And Development Expense | 2217000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001641172-25-009263 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 79000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Branded; Product Or Service= Other Revenues; | ||
| 0001641172-25-009263 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 20718000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Compounding; Product Or Service= Product Sales Net; | ||
| 0001641172-25-009263 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 20718000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Imprimis Rx; | ||
| 0001641172-25-009263 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 27780000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Branded; | ||
| 0001641172-25-009263 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 20051000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Compounding; Product Or Service= Product Sales Net; | ||
| 0001641172-25-009263 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 86000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Other Revenues; | ||
| 0001641172-25-009263 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 207995000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009263 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 69652000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001641172-25-009263 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 56096000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 35000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009263 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 2743.0000 | shares | 1 | us-gaap/2024 | Award Type= Employee Stock Option; Equity Components= Common Stock; | ||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Value Other | -1157000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009263 | 20240331 | Stock Issued During Period Value Other | -1157000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009263 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009263 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-009263 | 20250531 | Stock Issued During Period Value Restricted Stock Award Gross | 14382.0000 | USD | 0 | us-gaap/2024 | Award Type= Restricted Stock Units R S U; Equity Components= Common Stock; Subsequent Event Type= Subsequent Event; Title Of Individual= Consultants; | ||
| 0001641172-25-009263 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 23000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009263 | 20250331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Other Nonoperating Income | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income | Amount of income related to nonoperating activities, classified as other. |
| Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
| Insurance Premium Financed | 0001641172-25-009263 | 1 | 0 | monetary | D | C | Insurance premium financed | Insurance premium financed. |
| Depreciation And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Including Portion Attributable to Noncontrolling Interest | Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. |
| Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Restricted Stock Award, Gross | Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. | |
| Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable and Accrued Liabilities, Current | Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. |
| Gain Loss On Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss) on Investments | Amount of realized and unrealized gain (loss) on investment. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Proceeds From Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Interest Expense Nonoperating | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Nonoperating | Amount of interest expense classified as nonoperating. |
| Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Long Term Notes Payable | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes Payable, Noncurrent | Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Cost Of Goods And Services Sold | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Goods and Services Sold | The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Gross Profit | us-gaap/2024 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Payments To Acquire Intangible Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Intangible Assets | The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. |
| Accrued Rebates And Copay Assistance | 0001641172-25-009263 | 1 | 0 | monetary | I | C | Accrued rebates and copay assistance | Accrued rebates and copay assistance. |
| Selling General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Capital Expenditures Incurred But Not Yet Paid | us-gaap/2024 | 0 | 0 | monetary | D | C | Capital Expenditures Incurred but Not yet Paid | Future cash outflow to pay for purchases of fixed assets that have occurred. |
| Amortization Of Financing Costs And Discounts | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Debt Issuance Costs and Discounts | Amount of amortization expense attributable to debt discount (premium) and debt issuance costs. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Income Taxes Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid, Net | Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
| Increase Decrease In Employee Related Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Employee Related Liabilities | The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. |
| Increase Decrease In Inventories | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Payment Of Payroll Taxes Upon Vesting Of P S Us R S Us And Exercise Of Stock Options | 0001641172-25-009263 | 1 | 0 | monetary | D | C | Payment of payroll taxes upon vesting of PSUs, RSUs and exercise of stock options | Payment of payroll taxes upon vesting of PSUs, RSUs and exercise of stock options. |
| Capitalized Computer Software Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Capitalized Computer Software, Net | The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date. |
| Employee Related Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Employee-related Liabilities, Current | Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Goodwill | Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. |
| Intangible Assets Net Excluding Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Intangible Assets, Net (Excluding Goodwill) | Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Notes Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Stock Issued During Period Shares Other | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Other | Number of shares of stock issued attributable to transactions classified as other. | |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Inventory Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Amortization Of Intangible Assets | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Intangible Assets | The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Lease, Right-of-Use Asset, Periodic Reduction | Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease. |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Stock Issued During Period Value Restricted Stock Award Gross | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Restricted Stock Award, Gross | Aggregate value of stock related to Restricted Stock Awards issued during the period. |
| Change In Rightofuse Assets For Operating Lease Obligations Assumptions | 0001641172-25-009263 | 1 | 0 | monetary | D | C | Change in right-of-use assets for operating lease obligations assumptions | Change in right-of-use assets for operating lease obligations assumptions. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Contract With Customer Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Contract with Customer, Liability, Current | Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| Increase Decrease In Deferred Revenue | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Deferred Revenue | Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. |
| Minority Interest | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Noncontrolling Interest | Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Provision For Doubtful Accounts | us-gaap/2024 | 0 | 0 | monetary | D | D | Accounts Receivable, Credit Loss Expense (Reversal) | Amount of expense (reversal of expense) for expected credit loss on accounts receivable. |
| Stock Issued During Period Value Other | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Other | Value of shares of stock issued attributable to transactions classified as other. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-009263 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001641172-25-009263 | 2 | 4 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Accounts receivable, net | 0 |
| 0001641172-25-009263 | 2 | 5 | BS | 0 | H | Inventory Net | us-gaap/2024 | Inventories | 0 |
| 0001641172-25-009263 | 2 | 6 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0001641172-25-009263 | 2 | 7 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001641172-25-009263 | 2 | 8 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property, plant and equipment, net | 0 |
| 0001641172-25-009263 | 2 | 9 | BS | 0 | H | Capitalized Computer Software Net | us-gaap/2024 | Capitalized software costs, net | 0 |
| 0001641172-25-009263 | 2 | 10 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use assets, net | 0 |
| 0001641172-25-009263 | 2 | 11 | BS | 0 | H | Intangible Assets Net Excluding Goodwill | us-gaap/2024 | Intangible assets, net | 0 |
| 0001641172-25-009263 | 2 | 12 | BS | 0 | H | Goodwill | us-gaap/2024 | Goodwill | 0 |
| 0001641172-25-009263 | 2 | 13 | BS | 0 | H | Assets | us-gaap/2024 | TOTAL ASSETS | 0 |
| 0001641172-25-009263 | 2 | 16 | BS | 0 | H | Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
| 0001641172-25-009263 | 2 | 17 | BS | 0 | H | Accrued Rebates And Copay Assistance | 0001641172-25-009263 | Accrued rebates and copay assistance | 0 |
| 0001641172-25-009263 | 2 | 18 | BS | 0 | H | Employee Related Liabilities Current | us-gaap/2024 | Accrued payroll and related liabilities | 0 |
| 0001641172-25-009263 | 2 | 19 | BS | 0 | H | Contract With Customer Liability Current | us-gaap/2024 | Deferred revenue and customer deposits | 0 |
| 0001641172-25-009263 | 2 | 20 | BS | 0 | H | Notes Payable Current | us-gaap/2024 | Current portion of notes payable, net of unamortized debt discount | 0 |
| 0001641172-25-009263 | 2 | 21 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Current portion of operating lease obligations | 0 |
| 0001641172-25-009263 | 2 | 22 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001641172-25-009263 | 2 | 23 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease obligations, net of current portion | 0 |
| 0001641172-25-009263 | 2 | 24 | BS | 0 | H | Long Term Notes Payable | us-gaap/2024 | Notes payable, net of unamortized debt discount and current portion | 0 |
| 0001641172-25-009263 | 2 | 25 | BS | 0 | H | Liabilities | us-gaap/2024 | TOTAL LIABILITIES | 0 |
| 0001641172-25-009263 | 2 | 26 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies | 0 |
| 0001641172-25-009263 | 6 | 20 | CF | 0 | H | Payments To Acquire Intangible Assets | us-gaap/2024 | Investment in patent and trademark assets | 1 |
| 0001641172-25-009263 | 2 | 28 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.001 par value, 50,000,000 shares authorized, 35,654,171 and 35,622,214 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 0 |
| 0001641172-25-009263 | 2 | 29 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001641172-25-009263 | 2 | 30 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001641172-25-009263 | 2 | 31 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | TOTAL HARROW, INC. STOCKHOLDERS EQUITY | 0 |
| 0001641172-25-009263 | 2 | 32 | BS | 0 | H | Minority Interest | us-gaap/2024 | Noncontrolling interests | 0 |
| 0001641172-25-009263 | 2 | 33 | BS | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | TOTAL STOCKHOLDERS EQUITY | 0 |
| 0001641172-25-009263 | 2 | 34 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | TOTAL LIABILITIES AND STOCKHOLDERS EQUITY | 0 |
| 0001641172-25-009263 | 3 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0001641172-25-009263 | 3 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001641172-25-009263 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001641172-25-009263 | 3 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001641172-25-009263 | 4 | 8 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | Total revenues | 0 |
| 0001641172-25-009263 | 4 | 9 | IS | 0 | H | Cost Of Goods And Services Sold | us-gaap/2024 | Cost of sales | 1 |
| 0001641172-25-009263 | 4 | 10 | IS | 0 | H | Gross Profit | us-gaap/2024 | Gross profit | 0 |
| 0001641172-25-009263 | 4 | 12 | IS | 0 | H | Selling General And Administrative Expense | us-gaap/2024 | Selling, general and administrative | 0 |
| 0001641172-25-009263 | 4 | 13 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0001641172-25-009263 | 4 | 14 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001641172-25-009263 | 4 | 15 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0001641172-25-009263 | 4 | 17 | IS | 0 | H | Interest Expense Nonoperating | us-gaap/2024 | Interest expense, net | 1 |
| 0001641172-25-009263 | 4 | 18 | IS | 0 | H | Gain Loss On Investments | us-gaap/2024 | Investment loss from Eton Pharmaceuticals | 0 |
| 0001641172-25-009263 | 4 | 19 | IS | 0 | H | Other Nonoperating Income | us-gaap/2024 | Other income, net | 0 |
| 0001641172-25-009263 | 4 | 20 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other expense, net | 0 |
| 0001641172-25-009263 | 4 | 21 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-009263 | 4 | 22 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic net loss per share of common stock | 0 |
| 0001641172-25-009263 | 4 | 23 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted net loss per share of common stock | 0 |
| 0001641172-25-009263 | 4 | 24 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average number of shares of common stock outstanding, basic | 0 |
| 0001641172-25-009263 | 4 | 25 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average number of shares of common stock outstanding, diluted | 0 |
| 0001641172-25-009263 | 5 | 10 | EQ | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | Balance | 0 |
| 0001641172-25-009263 | 5 | 11 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-009263 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Exercise of employee stock-based options | 0 |
| 0001641172-25-009263 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Exercise of employee stock-based options, shares | 0 |
| 0001641172-25-009263 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Value Restricted Stock Award Gross | us-gaap/2024 | Vesting of RSUs | 0 |
| 0001641172-25-009263 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2024 | Vesting of RSUs, shares | 0 |
| 0001641172-25-009263 | 5 | 16 | EQ | 0 | H | Stock Issued During Period Value Other | us-gaap/2024 | Shares withheld related to net share settlement of equity awards | 0 |
| 0001641172-25-009263 | 5 | 17 | EQ | 0 | H | Stock Issued During Period Shares Other | us-gaap/2024 | Shares withheld related to net share settlement of equity awards, shares | 1 |
| 0001641172-25-009263 | 5 | 18 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation expense | 0 |
| 0001641172-25-009263 | 5 | 19 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-009263 | 5 | 20 | EQ | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | Balance | 0 |
| 0001641172-25-009263 | 5 | 21 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-009263 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-009263 | 6 | 4 | CF | 0 | H | Depreciation And Amortization | us-gaap/2024 | Depreciation and amortization of property, plant and equipment and software development costs | 0 |
| 0001641172-25-009263 | 6 | 5 | CF | 0 | H | Amortization Of Intangible Assets | us-gaap/2024 | Amortization of intangible assets | 0 |
| 0001641172-25-009263 | 6 | 6 | CF | 0 | H | Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2024 | Amortization of operating lease right-of-use assets | 0 |
| 0001641172-25-009263 | 6 | 7 | CF | 0 | H | Provision For Doubtful Accounts | us-gaap/2024 | Provision (recovery of) for credit losses | 0 |
| 0001641172-25-009263 | 6 | 8 | CF | 0 | H | Amortization Of Financing Costs And Discounts | us-gaap/2024 | Amortization of debt issuance costs and debt discount | 0 |
| 0001641172-25-009263 | 6 | 9 | CF | 0 | H | Gain Loss On Investments | us-gaap/2024 | Investment loss from investment in Eton | 1 |
| 0001641172-25-009263 | 6 | 10 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0001641172-25-009263 | 6 | 12 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Accounts receivable | 1 |
| 0001641172-25-009263 | 6 | 13 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2024 | Inventories | 1 |
| 0001641172-25-009263 | 6 | 14 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
| 0001641172-25-009263 | 6 | 15 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable, accrued expenses, accrued rebates and copay assistance | 0 |
| 0001641172-25-009263 | 6 | 16 | CF | 0 | H | Increase Decrease In Employee Related Liabilities | us-gaap/2024 | Accrued payroll and related liabilities | 0 |
| 0001641172-25-009263 | 6 | 17 | CF | 0 | H | Increase Decrease In Deferred Revenue | us-gaap/2024 | Deferred revenue and customer deposits | 0 |
| 0001641172-25-009263 | 6 | 18 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES | 0 |
| 0001641172-25-009263 | 6 | 21 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases of property, plant and equipment | 1 |
| 0001641172-25-009263 | 6 | 22 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | NET CASH USED IN INVESTING ACTIVITIES | 0 |
| 0001641172-25-009263 | 6 | 24 | CF | 0 | H | Payment Of Payroll Taxes Upon Vesting Of P S Us R S Us And Exercise Of Stock Options | 0001641172-25-009263 | Payment of payroll taxes upon vesting of PSUs, RSUs and exercise of stock options | 1 |
| 0001641172-25-009263 | 6 | 25 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2024 | Proceeds from exercise of stock options | 0 |
| 0001641172-25-009263 | 6 | 26 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES | 0 |
| 0001641172-25-009263 | 6 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | NET CHANGE IN CASH AND CASH EQUIVALENTS | 0 |
| 0001641172-25-009263 | 6 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | CASH AND CASH EQUIVALENTS, beginning of period | 0 |
| 0001641172-25-009263 | 6 | 29 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | CASH, CASH EQUIVALENTS, end of period | 0 |
| 0001641172-25-009263 | 6 | 31 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2024 | Cash paid for income taxes | 0 |
| 0001641172-25-009263 | 6 | 32 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest | 0 |
| 0001641172-25-009263 | 6 | 34 | CF | 0 | H | Capital Expenditures Incurred But Not Yet Paid | us-gaap/2024 | Purchase of property, plant and equipment included in accounts payable and accrued expenses | 0 |
| 0001641172-25-009263 | 6 | 35 | CF | 0 | H | Change In Rightofuse Assets For Operating Lease Obligations Assumptions | 0001641172-25-009263 | Change in right-of-use assets for operating lease obligations assumptions | 0 |
| 0001641172-25-009263 | 6 | 36 | CF | 0 | H | Insurance Premium Financed | 0001641172-25-009263 | Insurance premium financed | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |